{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Andrographis paniculata", "esophageal squamous cell carcinoma", "metastasis", "overall survival", "palliative management"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37042309", "DateCompleted": {"Year": "2023", "Month": "10", "Day": "23"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "04", "Day": "12"}], "Language": ["eng"], "ELocationID": ["10.1002/ptr.7815"], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "37", "Issue": "8", "PubDate": {"Year": "2023", "Month": "Aug"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "The effect of Andrographis paniculata water extract on palliative management of metastatic esophageal squamous cell carcinoma-A phase II clinical trial.", "Pagination": {"StartPage": "3438", "EndPage": "3452", "MedlinePgn": "3438-3452"}, "Abstract": {"AbstractText": ["Patients with metastatic esophageal squamous cell carcinoma (ESCC) have a grave prognosis with limited life expectancy. Here, a phase II clinical trial was conducted to investigate the effect of Andrographis paniculata (AP) on the palliative care of patients with metastatic ESCC. Patients with metastatic or locally advanced ESCC deemed unfit for surgery, and who have already completed palliative chemotherapy or chemoradiotherapy or are not fit for these treatments, were recruited. These patients were prescribed AP concentrated granules for 4\u2009months. They also received clinical and quality of life assessments for clinical response, as well as positron emission tomography-computed tomography at 3 and 6\u2009months after AP treatment for the assessment of tumor volume. Furthermore, the change in gut microbiota composition after AP treatment was studied. From the results, among the 30 recruited patients, 10 completed the entire course of AP treatment, while 20 received partial AP treatment. Patients who completed the AP treatment achieved significantly longer overall survival periods with the maintenance of the quality of life during the survival period when compared to those who could not complete AP treatment. The treatment effect of AP also contributed to the shift of the overall structure of gut microbiota for ESCC patients towards those of healthy individuals. The significance of this study is the establishment of AP as a safe and effective palliative treatment for patients with squamous cell carcinoma of the esophagus. To the best of our knowledge, this is the first clinical trial of AP water extract in esophageal cancer patients demonstrating its new medicinal use."], "CopyrightInformation": "\u00a9 2023 The Authors. Phytotherapy Research published by John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Upper GI and Metabolic Surgery, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong."}, {"Identifier": [], "Affiliation": "Institute of Digestive Disease and State Key Laboratory of Digestive Diseases, The Chinese University of Hong Kong, Shatin, Hong Kong."}], "LastName": "Chiu", "ForeName": "Philip Wai-Yan", "Initials": "PW"}, {"Identifier": ["0000-0002-1726-3566"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Yue", "ForeName": "Grace Gar-Lee", "Initials": "GG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Upper GI and Metabolic Surgery, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong."}], "LastName": "Cheung", "ForeName": "Man Kit", "Initials": "MK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Upper GI and Metabolic Surgery, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong."}, {"Identifier": [], "Affiliation": "Institute of Digestive Disease and State Key Laboratory of Digestive Diseases, The Chinese University of Hong Kong, Shatin, Hong Kong."}], "LastName": "Yip", "ForeName": "Hon-Chi", "Initials": "HC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nong's, PuraPharm Corporation Limited, Tai Po, Hong\u00a0Kong."}], "LastName": "Chu", "ForeName": "Siu-Kai", "Initials": "SK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Upper GI and Metabolic Surgery, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong."}, {"Identifier": [], "Affiliation": "Institute of Digestive Disease and State Key Laboratory of Digestive Diseases, The Chinese University of Hong Kong, Shatin, Hong Kong."}], "LastName": "Yung", "ForeName": "Man-Yee", "Initials": "MY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Digestive Disease and State Key Laboratory of Digestive Diseases, The Chinese University of Hong Kong, Shatin, Hong Kong."}, {"Identifier": [], "Affiliation": "Division of Gastroenterology and Hepatology, Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong."}], "LastName": "Wu", "ForeName": "Justin Che-Yuen", "Initials": "JC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Upper GI and Metabolic Surgery, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong."}, {"Identifier": [], "Affiliation": "Institute of Digestive Disease and State Key Laboratory of Digestive Diseases, The Chinese University of Hong Kong, Shatin, Hong Kong."}], "LastName": "Chan", "ForeName": "Shannon Melissa", "Initials": "SM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Upper GI and Metabolic Surgery, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong."}, {"Identifier": [], "Affiliation": "Institute of Digestive Disease and State Key Laboratory of Digestive Diseases, The Chinese University of Hong Kong, Shatin, Hong Kong."}], "LastName": "Teoh", "ForeName": "Anthony Yuen-Bun", "Initials": "AY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Upper GI and Metabolic Surgery, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong."}, {"Identifier": [], "Affiliation": "Institute of Digestive Disease and State Key Laboratory of Digestive Diseases, The Chinese University of Hong Kong, Shatin, Hong Kong."}], "LastName": "Ng", "ForeName": "Enders Kwok-Wai", "Initials": "EK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nong's, PuraPharm Corporation Limited, Tai Po, Hong\u00a0Kong."}], "LastName": "Norimoto", "ForeName": "Hisayoshi", "Initials": "H"}, {"Identifier": ["0000-0002-7409-1270"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong."}], "LastName": "Lau", "ForeName": "Clara Bik-San", "Initials": "CB"}], "GrantList": [{"GrantID": "ITS/079/17FX", "Agency": "Innovation and Technology Commission", "Country": ""}], "PublicationTypeList": ["Clinical Trial, Phase II", "Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Esophageal Squamous Cell Carcinoma"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Esophageal Neoplasms"}, {"QualifierName": [], "DescriptorName": "Andrographis paniculata"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Carcinoma, Squamous Cell"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Amir, A., McDonald, D., Navas-Molina, J. A., Kopylova, E., Morton, J. T., Zech Xu, Z., Kightley, E. P., Thompson, L. R., Hyde, E. R., Gonzalez, A., & Knight, R. (2017). Deblur rapidly resolves single-nucleotide community sequence patterns. mSystems, 2(2), e00191-16. https://doi.org/10.1128/mSystems.00191-16"}, {"Citation": "Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C. C., Al-Ghalith, G. A., Alexander, H., Alm, E. J., Arumugam, M., Asnicar, F., Bai, Y., Bisanz, J. E., Bittinger, K., Brejnod, A., Brislawn, C .J., Brown, C. T., Callahan, B. J., Caraballo-Rodriguez, A .M., Chase, J., & Caporaso, J. G. (2019). Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nature Biotechnology, 37(8), 852-857. https://doi.org/10.1038/s41587-019-0209-9"}, {"Citation": "Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394-424. https://doi.org/10.3322/caac.21492"}, {"Citation": "Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Lozupone, C. A., Turnbaugh, P. J., Fierer, N., & Knight, R. (2011). Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proceedings of the National Academy of Sciences of the United States of America, 108(Suppl 1), 4516-4522. https://doi.org/10.1073/pnas.1000080107"}, {"Citation": "Cheung, M. K., Yue, G. G. L., Gomes, A. J., Wong, E. C., Lee, J. K., Kwok, F. H., Chiu, P. W. Y., &\u00a0Lau, C. B. S. (2022). Network pharmacology reveals potential functional components and underlying molecular mechanisms of Andrographis paniculata in esophageal cancer treatment. Phytotherapy Research, 36, 1748-1760. https://doi.org/10.1002/ptr.7411"}, {"Citation": "Cheung, M. K., Yue, G. G. L., Lauw, S., Li, C. S. Y., Yung, M. Y., Ng, S. C., Yip, H. C., Kwan, H. S., Chiu, P. W. Y., & Lau, C. B. S. (2022). Alterations in gut microbiota of esophageal squamous cell carcinoma patients. Journal of Gastroenterology and Hepatology, In Press, 37, 1919-1927. https://doi.org/10.1111/jgh.15941"}, {"Citation": "Cheung, M. K., Yue, G. G. L., Tsui, K. Y., Gomes, A. J., Kwan, H. S., Chiu, P. W. Y., & Lau, C. B. S. (2020). Discovery of an interplay between the gut microbiota and esophageal squamous cell carcinoma in mice. American Journal of Cancer Research, 10(8), 2409-2427."}, {"Citation": "Chiu, P. W., Chan, A. C., Leung, S. F., Leong, H. T., Kwong, K. H., Li, M. K., Au-Yeung, A. C., Chung, S. C., & Ng, E. K. (2005). Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: Early results from the Chinese university research Group for Esophageal Cancer (CURE). Journal of Gastrointestinal Surgery, 9(6), 794-802. https://doi.org/10.1016/j.gassur.2005.05.005"}, {"Citation": "Chuah, X. Q., Mun, W., & Sen Teo, S. (2017). Comparison study of anti-microbial activity between crude extract of Kappaphycus alvarezii and Andrographis paniculata. Asian Pacific Journal of Tropical Biomedicine, 7(8), 729-731. https://doi.org/10.1016/j.apjtb.2017.07.003"}, {"Citation": "Chung, V. C. H., Wu, X., Lu, P., Hui, E. P., Zhang, Y., Zhang, A. L., Lau, A. Y. L., Zhao, J., Fan, M., Ziea, E. T. C., Ng, B. F. L., Wong, S. Y. S., &\u00a0Wu, J. C. Y. (2016). Chinese herbal medicine for symptom management in cancer palliative care: Systematic review and meta-analysis. Medicine (Baltimore), 95(7), e2793. https://doi.org/10.1097/MD.0000000000002793"}, {"Citation": "Commission, C. P. (2015). Pharmacopoeia of the People's Republic of China. China Medical Science Press."}, {"Citation": "Fleming, T. R. (1982). One-sample multiple testing procedure for phase II clinical trials. Biometrics, 38(1), 143-151."}, {"Citation": "Grunberger, B., Raderer, M., Schmidinger, M., & Hejna, M. (2007). Palliative chemotherapy for recurrent and metastatic esophageal cancer. Anticancer Research, 27(4C), 2705-2714."}, {"Citation": "Hossain, S., Urbi, Z., Karuniawati, H., Mohiuddin, R. B., Moh Qrimida, A., Allzrag, A. M. M., Ming, L. C., Pagano, E., &\u00a0Capasso, R. (2021). Andrographis paniculata (Burm. f.) wall. Ex Nees: An updated review of phytochemistry, antimicrobial pharmacology, and clinical safety and efficacy. Life (Basel), 11(4), 348. https://doi.org/10.3390/life11040348"}, {"Citation": "Huang, J., Koulaouzidis, A., Marlicz, W., Lok, V., Chu, C., Ngai, C. H., Zhang, L., Chen, P., Wang, S., Yuan, J., Lao, X. Q., Tse, S. L. A., Xu, W., Zheng, Z. J., Xie, S. H., &\u00a0Wong, M. C. S. (2021). Global burden, risk factors, and trends of esophageal cancer: An analysis of cancer registries from 48 countries. Cancers (Basel), 13(1), 141. https://doi.org/10.3390/cancers13010141"}, {"Citation": "Janmaat, V. T., Steyerberg, E. W., van der Gaast, A., Mathijssen, R. H., Bruno, M. J., Peppelenbosch, M. P., Kuipers, E. J., & Spaander, M. C. (2017). Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database of Systematic Reviews, 11, CD004063. https://doi.org/10.1002/14651858.CD004063.pub4"}, {"Citation": "Jin, X., Ruiz Beguerie, J., Sze, D. M., & Chan, G. C. (2016). Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database of Systematic Reviews, 4, CD007731. https://doi.org/10.1002/14651858.CD007731.pub3"}, {"Citation": "Kim, E. J., Kim, J. H., Song, H. J., Park, S. R., Kim, Y. H., Kim, H. R., & Kim, S. B. (2020). Impact of sequential lines of palliative chemotherapy in patients with recurrent/metastatic esophageal squamous cell carcinoma: A retrospective analysis of 107 patients at a single center. Asia-Pacific Journal of Clinical Oncology, 16(2), e53-e62. https://doi.org/10.1111/ajco.13283"}, {"Citation": "Kim, S., DiPeri, T. P., Guan, M., Placencio-Hickok, V. R., Kim, H., Liu, J. Y., Hendifar, A., Klempner, S. J., Nipp, R., Gangi, A., Burch, M., Waters, K., Cho, M., Chao, J., Atkins, K., Kamrava, M., Tuli, R., & Gong, J. (2020). Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy. World Journal of Gastrointestinal Surgery, 12(9), 377-389. https://doi.org/10.4240/wjgs.v12.i9.377"}, {"Citation": "Li, L., Yue, G. G. L., Lee, J. K., Wong, E. C., Fung, K. P., Yu, J., Lau, C. B. S., & Chiu, P. W. Y. (2017). The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment - from preclinical perspectives. Scientific Reports, 7(1), 854. https://doi.org/10.1038/s41598-017-00934-x"}, {"Citation": "Li, L., Yue, G. G. L., Lee, J. K., Wong, E. C., Fung, K. P., Yu, J., Lau, C. B. S., & Chiu, P. W. (2018). Gene expression profiling reveals the plausible mechanisms underlying the antitumor and antimetastasis effects of Andrographis paniculata in esophageal cancer. Phytotherapy Research, 32(7), 1388-1396. https://doi.org/10.1002/ptr.6074"}, {"Citation": "Opstelten, J. L., de Wijkerslooth, L. R., Leenders, M., Bac, D. J., Brink, M. A., Loffeld, B. C., Meijnen-Bult, M. J., Minderhoud, I. M., Verhagen, M. A., van Oijen, M. G., & Siersema, P. D. (2017). Variation in palliative care of esophageal cancer in clinical practice: Factors associated with treatment decisions. Diseases of the Esophagus, 30(2), 1-7. https://doi.org/10.1111/dote.12478"}, {"Citation": "Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., & Glockner, F. O. (2013). The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Research, 41(Database issue), D590-D596. https://doi.org/10.1093/nar/gks1219"}, {"Citation": "Rajanna, M., Bharathi, B., Shivakumar, B. R., Deepak, M., Prashanth, D., Prabakaran, D., Vijayabhaskar, T., & Arun, B. (2021). Immunomodulatory effects of Andrographis paniculata extract in healthy adults - an open-label study. Journal of Ayurveda and Integrative Medicine, 12(3), 529-534. https://doi.org/10.1016/j.jaim.2021.06.004"}, {"Citation": "Survival rates for esophageal cancer. (2020). Retrieved from https://www.cancer.org/cancer/esophagus-cancer/detection-diagnosis-staging.html"}, {"Citation": "Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017). GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Research, 45(W1), W98-W102. https://doi.org/10.1093/nar/gkx247"}, {"Citation": "Teoh, A. Y., Chiu, P. W., Yeung, W. K., Liu, S. Y., Wong, S. K., & Ng, E. K. (2013). Long-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: Results from a randomized controlled trial. Annals of Oncology, 24(1), 165-171. https://doi.org/10.1093/annonc/mds206"}, {"Citation": "Teoh, A. Y., Chiu, P. W. Y., Wong, T. C., Liu, S. Y. W., Wong, S. K. H., & Ng, E. K. W. (2011). Functional performance and quality of life in patients with squamous esophageal carcinoma receiving surgery or chemoradiation: Results from a randomized trial. Annals of Surgery, 253(1), 1-5. https://doi.org/10.1097/SLA.0b013e3181fcd991"}, {"Citation": "van Rossum, P. S. N., Mohammad, N. H., Vleggaar, F. P., & van Hillegersberg, R. (2018). Treatment for unresectable or metastatic oesophageal cancer: Current evidence and trends. Nature Reviews. Gastroenterology & Hepatology, 15(4), 235-249. https://doi.org/10.1038/nrgastro.2017.162"}, {"Citation": "Vences-Catalan, F., Rajapaksa, R., Kuo, C. C., Miller, C. L., Lee, A., Ramani, V. C., Jeffrey, S. S., Levy, R., & Levy, S. (2021). Targeting the tetraspanin CD81 reduces cancer invasion and metastasis. Proceedings of the National Academy of Sciences of the United States of America, 118(24), e2018961118. https://doi.org/10.1073/pnas.2018961118"}, {"Citation": "Wong, M. C. S., Hamilton, W., Whiteman, D. C., Jiang, J. Y., Qiao, Y., Fung, F. D. H., Wang, H. H. X., Chiu, P. W. Y., Ng, E. K. W., Wu, J. C. Y., Yu, J., Chan, F. K. L., &\u00a0Sung, J. J. Y. (2018). Global incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries. Scientific Reports, 8(1), 4522. https://doi.org/10.1038/s41598-018-19819-8"}, {"Citation": "Wong, S. K., Chiu, P. W., Leung, S. F., Cheung, K. Y., Chan, A. C., Au-Yeung, A. C., Griffith, J. F., Chung, S. S., & Ng, E. K. (2008). Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: A case-control study. Annals of Surgical Oncology, 15(2), 576-582. https://doi.org/10.1245/s10434-007-9679-y"}, {"Citation": "Worakunphanich, W., Thavorncharoensap, M., Youngkong, S., Thadanipon, K., & Thakkinstian, A. (2021). Safety of Andrographis paniculata: A systematic review and meta-analysis. Pharmacoepidemiology and Drug Safety, 30(6), 727-739. https://doi.org/10.1002/pds.5190"}, {"Citation": "Yue, G. G. L., Gomes, A. J., Saeed, M. E. M., Tsui, K. Y., Dawood, M., Drif, A. I., Wong, E. C. W., Lee, W. F., Liu, W., Chiu, P. W. Y., Efferth, T., & Lau, C. B. S. (2022). Identification of active components in Andrographis paniculata targeting on CD81 in esophageal cancer in vitro and in vivo. Phytomedicine, 102, 154183. https://doi.org/10.1016/j.phymed.2022.154183"}, {"Citation": "Yue, G. G. L., Lee, J. K., Li, L., Chan, K. M., Wong, E. C., Chan, J. Y., Fung, K. P., Lui, V. W., Chiu, P. W. Y., & Lau, C. B. S. (2015). Andrographis paniculata elicits anti-invasion activities by suppressing TM4SF3 gene expression and by anoikis-sensitization in esophageal cancer cells. American Journal of Cancer Research, 5(12), 3570-3587."}, {"Citation": "Yue, G. G. L., Li, L., Lee, J. K., Kwok, H. F., Wong, E. C., Li, M., Fung, K. P., Yu, J., Chan, A. W., Chiu, P. W. Y., & Lau, C. B. S. (2019). Multiple modulatory activities of Andrographis paniculata on immune responses and xenograft growth in esophageal cancer preclinical models. Phytomedicine, 60, 152886. https://doi.org/10.1016/j.phymed.2019.152886"}, {"Citation": "Zhang, F., Wang, Y., Wang, Z. Q., Sun, P., Wang, D. S., Jiang, Y. X., Zhang, D. S., Wang, F. H., Xu, R. H., & Li, Y. H. (2017). Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis. Diseases of the Esophagus, 30(2), 1-8. https://doi.org/10.1111/dote.12490"}, {"Citation": "Zhou, Z., Ran, Y. L., Hu, H., Pan, J., Li, Z. F., Chen, L. Z., Sun, L. C., Peng, L., Zhao, X. L., Yu, L., Sun, L. X., & Yang, Z. H. (2008). TM4SF3 promotes esophageal carcinoma metastasis via upregulating ADAM12m expression. Clinical & Experimental Metastasis, 25(5), 537-548. https://doi.org/10.1007/s10585-008-9168-0"}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2023", "Month": "3", "Day": "13"}, {"Year": "2022", "Month": "8", "Day": "6"}, {"Year": "2023", "Month": "3", "Day": "18"}, {"Year": "2023", "Month": "10", "Day": "23", "Hour": "12", "Minute": "45"}, {"Year": "2023", "Month": "4", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "4", "Day": "12", "Hour": "5", "Minute": "32"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37042309", "10.1002/ptr.7815"]}}], "PubmedBookArticle": []}